Ceterix CEO John McCutcheon Is Writing a Different Ending with New Tech That Can Save the Meniscus

Medtech Talk

English - April 26, 2018 04:00 - 35 minutes - 16.3 MB - ★★★★★ - 56 ratings
Investing Business Health & Fitness medtech medical device venture capital health care innovation cardiology start-ups orthopedics digital health fda Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Intact CEO Bruce Shook Excited by New Round, Clinical Progress, and the Potential for Spin-off, Vesper

Next Episode: NxThera CEO Bob Paulson Talks M&A, Career Twists, Family, and Lessons Learned from Selling Yogurt

In 2010, John McCutcheon joined Ceterix, a start-up with big goals and a surer FDA path than his previous company. McCutcheon recounts the FDA's battering of that company, Emphasys, and explains how his current company is rolling today.